57
Participants
Start Date
July 31, 2012
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
Placebo to BI 144807
multiple dose (bid)
BI 144807
multiple dose (bid, low to high dose)
1313.2.44001 Boehringer Ingelheim Investigational Site, Manchester
Lead Sponsor
Boehringer Ingelheim
INDUSTRY